We are live on ! Find out more
Lazard Asset Management

Lazard Asset Management Portfolio holdings

AUM $60.8B
1-Year Est. Return 22.47%
This Fund
S&P 500
This Quarter Est. Return
-1.32%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$65.1B
AUM Growth
-$3.23B
Cap. Flow
-$6.27B
Cap. Flow %
-9.63%
Top 10 Hldgs %
24.01%
Holding
2,638
New
236
Increased
958
Reduced
794
Closed
308

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$365M
2
QCOM icon
Qualcomm
QCOM
+$297M
3
TT icon
Trane Technologies
TT
+$221M
4
CRM icon
Salesforce
CRM
+$194M
5
EFX icon
Equifax
EFX
+$161M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$582M
2
NSC icon
Norfolk Southern
NSC
+$323M
3
UNH icon
UnitedHealth
UNH
+$309M
4
CVS icon
CVS Health
CVS
+$238M
5
HON icon
Honeywell
HON
+$235M

Sector Composition

Rank Sector Weight
1 Technology 24.37%
2 Financials 15.12%
3 Healthcare 11.44%
4 Industrials 11.07%
5 Consumer Discretionary 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNDX icon
2351
Syndax Pharmaceuticals
SNDX
$1.76B
-11,602
Closed -$153K
SON icon
2352
Sonoco
SON
$5.64B
-26,938
Closed -$1.31M
SONO icon
2353
Sonos
SONO
$1.83B
-61,640
Closed -$927K
SPTN
2354
DELISTED
SpartanNash
SPTN
-39,448
Closed -$722K
STAA icon
2355
STAAR Surgical
STAA
$1.15B
-86,771
Closed -$2.11M
STIM icon
2356
Neuronetics
STIM
$157M
$0 ﹤0.01%
114
-636
-85% -$2.32K
STKS icon
2357
The ONE Group
STKS
$54.3M
-252
Closed
STOK icon
2358
Stoke Therapeutics
STOK
$2.06B
-58
Closed
TAYD icon
2359
Taylor Devices
TAYD
$171M
-174
Closed -$7K
TCRX icon
2360
TScan Therapeutics
TCRX
$49.9M
-70
Closed
TECH icon
2361
Bio-Techne
TECH
$11.2B
-16
Closed -$1K
THFF icon
2362
First Financial Corp
THFF
$981M
-7,819
Closed -$360K
THTX
2363
DELISTED
Theratechnologies
THTX
$0 ﹤0.01%
+490
New +$818
TNYA icon
2364
Tenaya Therapeutics
TNYA
$157M
-77
Closed
TOST icon
2365
Toast
TOST
$20.1B
-24
Closed
TRAK icon
2366
ReposiTrak
TRAK
$158M
-155
Closed -$3K
TROW icon
2367
T. Rowe Price
TROW
$24.2B
-15
Closed -$1K
TRUE
2368
DELISTED
TrueCar
TRUE
-128,074
Closed -$477K
TSHA icon
2369
Taysha Gene Therapies
TSHA
$1.82B
-154
Closed
TWIN icon
2370
Twin Disc
TWIN
$337M
$0 ﹤0.01%
+68
New +$660
TXT icon
2371
Textron
TXT
$15.1B
-179
Closed -$13K
TYL icon
2372
Tyler Technologies
TYL
$12.5B
-2,859
Closed -$1.65M
TZOO icon
2373
Travelzoo
TZOO
$73.4M
-4,408
Closed -$87K
UFPT icon
2374
UFP Technologies
UFPT
$2.41B
-345
Closed -$84K
UMH
2375
UMH Properties
UMH
$1.34B
-2,087
Closed -$39K

Similar funds

Lazard Asset Management's Q1 2025 Portfolio in Review

As of Q1 2025, Lazard Asset Management held 2,638 positions worth $65.1B, down 4.7% from $68.4B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Lazard Asset Management withdrew a net $6.27B in Q1 2025, closing 308 positions and reducing 794 holdings. Its most notable exit was Church & Dwight Co, an estimated $9.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Lazard Asset Management opened a new position in ScottsMiracle-Gro worth $58.9M.

  • Lazard Asset Management's largest Q1 2025 buy was ScottsMiracle-Gro: 1,072,791 shares worth $58.9M.
  • Lazard Asset Management added most to Apple in Q1 2025, an estimated $365M increase.
  • Lazard Asset Management's biggest Q1 2025 reduction was Amazon, cutting an estimated $582M.
  • Lazard Asset Management fully exited Church & Dwight Co in Q1 2025, selling an estimated $9.4M.
  • Lazard Asset Management's ten largest holdings make up 24% of its $65.1B portfolio in Q1 2025.
  • Lazard Asset Management opened 236 new positions and closed 308 in Q1 2025.
  • Lazard Asset Management's portfolio value fell 4.7% quarter-over-quarter to $65.1B.

Based on Lazard Asset Management's 13F filing for Q1 2025, filed 15 May 2025.